Who owns Odyssey Therapeutics?

Odyssey Therapeutics is currently owned by Jeito Capital, through Jeito II, since 2025.

When did Jeito Capital acquire Odyssey Therapeutics?

Jeito Capital acquired Odyssey Therapeutics in 2025 (active for 1 year).

Home/Companies/Biotech/Odyssey Therapeutics

Odyssey Therapeutics

Biotech·

US·Active·1yr hold

Odyssey Therapeutics is a healthcare company, headquartered in France.

Entry

2025

Hold

1yr

Status

Active

Est. EV

–

Most recent investor

Jeito Capital

2 ownership periods

Key facts

HQFrance

SectorHealthcare

Massachusetts-based clinical-stage biotech developing immunology and oncology therapeutics; Jeito Capital led USD 213M Series D August 2025…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Jeito II

Other portfolio companies in the same fund.

Augustine Therapeutics

Active

More PE-backed in Biotech

Comparable biotech deals from other GPs.

AdBio PartnersBelgium

Last updated April 2026 · Sourced from public filings